• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. Aug 1977; 17(2): 395–401.
PMCID: PMC421134

Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Abstract

Clostridium botulinum type D progenitor toxin was purified. The addition of ribonucleic acid to the whole culture helped initial acid precipitation of the toxin. As with type B, both L (16S) and M toxins (12S) obtained from a hemagglutinin-positive strain, whereas M toxin only was produced by a hemagglutinin-negative strain. M toxin (molecular weight, 300,000) consisted of one molecule each of a toxic (molecular weight, 170,000) and a nontoxic component (molecular weight, 130,000); L toxin consisted of both components plus hemagglutinin. The specific toxicity of M toxin was 5 X 10(8) mean lethal doses per mg of N; that of L toxin was 2.4 X 10(8) mean lethal doses per mg of N. These toxins were fully or nearly fully active, but in un-nicked form. Trypsinization caused nicking in the toxic component, forming a molecule made up of two peptide chains with molecular weights of 110,000 and 60,000; there was little or no increase in toxicity. The toxic component of type D was not antigenically related to that of type C, whereas the nontoxic component was antigenically indistinguishable from that of type C. The toxicities of both L nad M toxins of the hemagglutinin-positive strain were increased twofold by trypsinization. Neither toxin contained the C2 toxic factor elaborated by C and D strain.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Beers WH, Reich E. Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem. 1969 Aug 25;244(16):4473–4479. [PubMed]
  • Boroff DA, Fleck U. Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum. J Bacteriol. 1966 Nov;92(5):1580–1581. [PMC free article] [PubMed]
  • BOWMER EJ. PREPARATION AND ASSAY OF THE INTERNATIONAL STANDARDS FOR CLOSTRIDIUM BOTULINUM TYPES A, B, C, D AND E ANTITOXINS. Bull World Health Organ. 1963;29:701–709. [PMC free article] [PubMed]
  • CARDELLA MA, DUFF JT, WINGFIELD BH, GOTTFRIED C. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid. J Bacteriol. 1960 Mar;79:372–378. [PMC free article] [PubMed]
  • Dasgupta BR, Boroff DA, Rothstein E. Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A. Biochem Biophys Res Commun. 1966 Mar 22;22(6):750–756. [PubMed]
  • Eklund MW, Poysky FT. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol. 1972 Jul;24(1):108–113. [PMC free article] [PubMed]
  • Eklund MW, Poysky FT. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl Microbiol. 1974 Jan;27(1):251–258. [PMC free article] [PubMed]
  • Inoue K, Iida H. Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Jpn J Med Sci Biol. 1971 Feb;24(1):53–56. [PubMed]
  • Jansen BC. The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J Vet Res. 1971 Jun;38(2):93–98. [PubMed]
  • Jansen BC, Knoetze PC. Tryptic activation of Clostridium botulinum type C beta toxin. Onderstepoort J Vet Res. 1971 Dec;38(4):237–238. [PubMed]
  • Kitamura M, Sakaguchi S, Sakaguchi G. Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta. 1968 Oct 21;168(2):207–217. [PubMed]
  • Kozaki S, Sakaguchi G. Antigenicites of fragments of Clostridium botulinum type B derivative toxin. Infect Immun. 1975 May;11(5):932–936. [PMC free article] [PubMed]
  • Kozaki S, Sakaguchi S, Sakaguchi G. Purification and some properties of progenitor toxins of Clostridium botulinum type B. Infect Immun. 1974 Oct;10(4):750–756. [PMC free article] [PubMed]
  • Kozaki S, Sugii S, Oishi I, Sakaguchi S, Sakaguchi G. Proceedings: Clostridium botulinum type A, B, E and F 12S toxins. Jpn J Med Sci Biol. 1975 Feb;28(1):70–72. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Oishi I, Sakaguchi G. Purification of Clostridium botuliunum type F progenitor toxin. Appl Microbiol. 1974 Dec;28(6):923–928. [PMC free article] [PubMed]
  • Ohishi I, Sakaguchi G. Molecular construction of Clostridium botulinum type F progenitor toxin. Appl Microbiol. 1975 Apr;29(4):444–447. [PMC free article] [PubMed]
  • Ohishi I, Sakaguchi G. Activation of botulinum toxins in the absence of nicking. Infect Immun. 1977 Aug;17(2):402–407. [PMC free article] [PubMed]
  • REISFELD RA, LEWIS UJ, WILLIAMS DE. Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature. 1962 Jul 21;195:281–283. [PubMed]
  • Sakaguchi G, Sakaguchi S. Development of antibody to each component of Clostridium botulinum type E progenitor toxin. Jpn J Med Sci Biol. 1973 Dec;26(5):187–195. [PubMed]
  • Sakaguchi G, Sakaguchi S, Kozaki S, Sugii S, Oishi I. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography. Jpn J Med Sci Biol. 1974 Jun;27(3):161–172. [PubMed]
  • Shimizu T, Izumi N, Kondo H. Proceedings: Immunological specificities of Clostridium botulinum type C and D toxins. Jpn J Med Sci Biol. 1975 Oct-Dec;28(5-6):298–301. [PubMed]
  • STERNE M. Hemagglutination by Clostridium botulinum type D. Science. 1954 Apr 2;119(3092):440–441. [PubMed]
  • Sugii S, Sakaguchi G. Molecular construction of Clostridium botulinum type A toxins. Infect Immun. 1975 Dec;12(6):1262–1270. [PMC free article] [PubMed]
  • Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed]
  • WENTZEL LM, STERNE M, POLSON A. High toxicity of pure botulinum type D toxin. Nature. 1950 Oct 28;166(4226):739–740. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...